Loading
Yanuki
SUBCATEGORY FEED
AstraZeneca's Imfinzi, Roche's China Expansion, and Bladder Cancer Advancements | AstraZeneca's Imfinzi, Roche's China Expansion, and Bladder Cancer Advancements

Pharma / Oncology

AstraZeneca's Imfinzi, Roche's China Expansion, and Bladder Cancer Advancements

This article summarizes key developments in the pharmaceutical industry, including AstraZeneca's positive Phase 3 trial results for Imfinzi, Roche's investment in a new manufacturing site in China, and promising advancements in bladder canc...

AstraZeneca's Imfinzi, Roche's China Expansion, and Bladder Cancer Advancements Image via FirstWord Pharma
AstraZeneca's Imfinzi hits main goal of bladder cancer study, with "no detriment" to survival
Clinical Trials Executive Moves Oncology